LGND

Ligand Pharmaceuticals Incorporated - Common Stock (LGND)

About Ligand Pharmaceuticals Incorporated - Common Stock (LGND)

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in Jupiter, FL.

Details

Daily high

$202.50

Daily low

$197.81

Price at open

$197.87

52 Week High

$212.49

52 Week Low

$93.58

Market cap

3.9B

Dividend yield

0.00%

Volume

429,861

Avg. volume

242,125

P/E ratio

96.42

Ligand Pharmaceuticals Incorporated - Common Stock News